These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 23714318)

  • 1. Evaluation of ocular surface disease in patients with glaucoma.
    Mathews PM; Ramulu PY; Friedman DS; Utine CA; Akpek EK
    Ophthalmology; 2013 Nov; 120(11):2241-8. PubMed ID: 23714318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between OSDI questionnaire and ocular surface changes in glaucomatous patients.
    Guarnieri A; Carnero E; Bleau AM; Alfonso-Bartolozzi B; Moreno-Montañés J
    Int Ophthalmol; 2020 Mar; 40(3):741-751. PubMed ID: 31813109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ocular surface disease and quality of life in patients with glaucoma.
    Skalicky SE; Goldberg I; McCluskey P
    Am J Ophthalmol; 2012 Jan; 153(1):1-9.e2. PubMed ID: 21872203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical glaucoma therapy and ocular surface disease: a prospective, controlled cohort study.
    Saade CE; Lari HB; Berezina TL; Fechtner RD; Khouri AS
    Can J Ophthalmol; 2015 Apr; 50(2):132-6. PubMed ID: 25863853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical cyclosporine to control ocular surface disease in patients with chronic glaucoma after long-term usage of topical ocular hypotensive medications.
    Saini M; Dhiman R; Dada T; Tandon R; Vanathi M
    Eye (Lond); 2015 Jun; 29(6):808-14. PubMed ID: 25857609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ocular Surface Disease in Patients under Topical Treatment for Glaucoma.
    Pérez-Bartolomé F; Martínez-de-la-Casa JM; Arriola-Villalobos P; Fernández-Pérez C; Polo V; García-Feijoó J
    Eur J Ophthalmol; 2017 Nov; 27(6):694-704. PubMed ID: 28497458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ocular Surface Disease in Glaucoma: Effect of Polypharmacy and Preservatives.
    Ramli N; Supramaniam G; Samsudin A; Juana A; Zahari M; Choo MM
    Optom Vis Sci; 2015 Sep; 92(9):e222-6. PubMed ID: 25730335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Signs and symptoms of ocular surface disease in patients on topical intraocular pressure-lowering therapy].
    Gomes B; Turiel PR; Marques FP; Bernardo FP; Safady MV; Portes AL; Santhiago MR
    Arq Bras Oftalmol; 2013 Oct; 76(5):282-7. PubMed ID: 24232941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of ocular surface disease in glaucoma patients with benzalkonium chloride-preserved latanoprost eye drops: a short-term longitudinal study.
    Su CC; Lee YC; Lee PRC
    Graefes Arch Clin Exp Ophthalmol; 2021 May; 259(5):1243-1251. PubMed ID: 33433642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of ocular surface complaints in patients with glaucoma using topical intraocular pressure-lowering medications.
    Fechtner RD; Godfrey DG; Budenz D; Stewart JA; Stewart WC; Jasek MC
    Cornea; 2010 Jun; 29(6):618-21. PubMed ID: 20386433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-term tolerability of once-daily timolol hemihydrate 0.5%, timolol maleate in sorbate 0.5%, and generic timolol maleate gel-forming solution 0.5% in glaucoma and/or ocular hypertension: a prospective, randomized, double-masked, active-controlled, three-period crossover pilot study.
    Sonty S; Mundorf TK; Stewart JA; Stewart WC
    Clin Ther; 2009 Oct; 31(10):2063-71. PubMed ID: 19922877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of Virtual Reality Simulation to Identify Vision-Related Disability in Patients With Glaucoma.
    Lam AKN; To E; Weinreb RN; Yu M; Mak H; Lai G; Chiu V; Wu K; Zhang X; Cheng TPH; Guo PY; Leung CKS
    JAMA Ophthalmol; 2020 May; 138(5):490-498. PubMed ID: 32191274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality of Life and Primary Open-Angle Glaucoma in the Ocular Hypertension Treatment Study.
    Gordon MO; Gao F; Burkland J; Huecker JB; Gardiner SK; Ramulu P; Zangwill LM; Heuer DK; Higginbotham EJ; Parrish RK; Kass MA
    JAMA Ophthalmol; 2024 Oct; 142(10):935-942. PubMed ID: 39207774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Impact of Visual Field Clusters on Performance-based Measures and Vision-Related Quality of Life in Patients With Glaucoma.
    Sun Y; Lin C; Waisbourd M; Ekici F; Erdem E; Wizov SS; Hark LA; Spaeth GL
    Am J Ophthalmol; 2016 Mar; 163():45-52. PubMed ID: 26701273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High Prevalence of Ocular Surface Disease Among Glaucoma Patients in Thailand.
    Ruangvaravate N; Prabhasawat P; Vachirasakchai V; Tantimala R
    J Ocul Pharmacol Ther; 2018 Jun; 34(5):387-394. PubMed ID: 29596033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of signs and symptoms of ocular surface disease in individuals treated and not treated with glaucoma medication.
    Ghosh S; O'Hare F; Lamoureux E; Vajpayee RB; Crowston JG
    Clin Exp Ophthalmol; 2012; 40(7):675-81. PubMed ID: 22394358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective laser trabeculoplasty versus drops for newly diagnosed ocular hypertension and glaucoma: the LiGHT RCT.
    Gazzard G; Konstantakopoulou E; Garway-Heath D; Garg A; Vickerstaff V; Hunter R; Ambler G; Bunce C; Wormald R; Nathwani N; Barton K; Rubin G; Morris S; Buszewicz M
    Health Technol Assess; 2019 Jun; 23(31):1-102. PubMed ID: 31264958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinico-cytological analysis of conjunctiva and ocular surface symptoms of patients on topical anti-glaucoma medications attending Lagos University Teaching Hospital, Lagos, Nigeria: A case-control study.
    Aribaba OT; Adenekan OA; Alabi AS; Aina MT; Anunobi CC; Onakoya AO
    Niger Postgrad Med J; 2023; 30(3):240-249. PubMed ID: 37675701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ocular surface changes in primary open-angle glaucoma on anti-glaucoma medications versus treatment-naïve patients.
    Srivastava K; Bhatnagar KR; Shakrawal J; Tandon M; Jaisingh K; Pandey L; Roy F
    Indian J Ophthalmol; 2024 Mar; 72(3):374-380. PubMed ID: 38099355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of topical autologous serum on the ocular surface in patients with toxic corneal epitheliopathy induced by anti-glaucoma drugs.
    Yoon CH; Lee HJ; Park HY; Kim H; Kim MK; Jeoung JW; Oh JY
    Int Ophthalmol; 2020 Mar; 40(3):547-552. PubMed ID: 31705358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.